Last reviewed · How we verify
LTOT 24 h/day — Competitive Intelligence Brief
marketed
Respiratory/Pulmonary
Small molecule
Live · refreshed every 30 min
Target snapshot
LTOT 24 h/day (LTOT 24 h/day) — Skane University Hospital. LTOT 24 h/day delivers supplemental oxygen continuously throughout the day and night to maintain adequate blood oxygen levels in patients with chronic hypoxemia.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| LTOT 24 h/day TARGET | LTOT 24 h/day | Skane University Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- LTOT 24 h/day CI watch — RSS
- LTOT 24 h/day CI watch — Atom
- LTOT 24 h/day CI watch — JSON
- LTOT 24 h/day alone — RSS
Cite this brief
Drug Landscape (2026). LTOT 24 h/day — Competitive Intelligence Brief. https://druglandscape.com/ci/ltot-24-h-day. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab